Ozette
“High-Resolution Immune Profiling”
Ozette’s immune profiling platform uses cutting edge A.I. to provide insights that help answer some of the most pressing questions, such as whether or not a therapy works for an individual patient or if we can determine a patient’s disease before they have physical manifestations. Answering these critical questions and understanding the complexity of the immune system in health and disease helps scientists and doctors to drive towards better patient outcomes.
Ozette has raised $6MM in seed funding from Madrona Venture Group and Vulcan Capital and $6MM in grant funding.
Founders
Ali Ansary, PhD
Greg Finak, PhD
